ouabain has been researched along with calmidazolium in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Orlov, SN; Panyushkina, EA; Petrunyaka, VV; Severina, EP | 1 |
| Iqbal, Z; Sze, PY | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
4 other study(ies) available for ouabain and calmidazolium
| Article | Year |
|---|---|
The ATPase activity of saponin-treated rat erythrocytes: regulation by monovalent cations, calcium, ouabain, and furosemide.
Topics: Adenosine Triphosphatases; Animals; Buffers; Ca(2+) Mg(2+)-ATPase; Calcium; Calcium-Transporting ATPases; Calmodulin; Cations, Monovalent; Cell Membrane Permeability; Dose-Response Relationship, Drug; Epithelium; Furosemide; Imidazoles; Kidney; Kinetics; Male; Ouabain; Rats; Saponins; Sodium-Potassium-Exchanging ATPase | 1990 |
Ethanol modulates calmodulin-dependent Ca(2+)-activated ATPase in synaptic plasma membranes.
Topics: Alcoholism; Animals; Brain; Calcium-Transporting ATPases; Ethanol; Imidazoles; Kinetics; Male; Ouabain; Rats; Rats, Sprague-Dawley; Reference Values; Synaptic Membranes; Synaptosomes; Trifluoperazine | 1994 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |